Assembly Biosciences (FRA:V7B) YoY EPS Growth : 48.65% (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Assembly Biosciences YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Assembly Biosciences's YoY EPS Growth for the quarter that ended in Jun. 2024 was 48.65%.

Assembly Biosciences's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was €-1.84.

Assembly Biosciences YoY EPS Growth Historical Data

The historical data trend for Assembly Biosciences's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assembly Biosciences YoY EPS Growth Chart

Assembly Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

4.30

57.03

-84.57

31.61

43.69

Assembly Biosciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
YoY EPS Growth	Get a 7-Day Free Trial															38.15	47.82	69.59	63.35	48.65

Assembly Biosciences YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Assembly Biosciences's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-12.269	-	-21.788)	/	\| -21.788 \|
=	43.69 %

Assembly Biosciences's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EPS Growth (Q: Jun. 2024 )
=	(Earnings per Share (Diluted) (Q: Jun. 2024 )	-	Earnings per Share (Diluted) (Q: Jun. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Jun. 2023 )) \|
=	(-1.839	-	-3.581)	/	\| -3.581 \|
=	48.65 %

Assembly Biosciences YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Assembly Biosciences's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Assembly Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Assembly Biosciences Inc (FRA:V7B) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

ASMB:USA

Address

331 Oyster Point Boulevard, Fourth Floor, South San Francisco, CA, USA, 94080

Website

https://www.assemblybio.com

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, that are designed to restore health to a dysbiotic microbiome. The firm's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Its program targets high-recurrence genital herpes associated with herpes simplex virus type 2 (HSV-2) infection and research programs focused on the discovery of novel antivirals to treat devastating viral diseases, including hepatitis delta virus (HDV) and transplant-related herpesviruses.

Assembly Biosciences Headlines

No Headlines